Related Experiment Video
Updated: Jun 21, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cells
Mauro Salvi1, Dong Xu, Yingyu Chen
1Department of Biological Chemistry, University of Padova, Viale G. Colombo 3, Padua, Italy. mauro.salvi@unipd.it
Abstract:
CK2 is a multifunctional kinase, involved in cell growth, apoptosis, DNA integrity preservation, viral infection, and many other biological processes. Based on an analysis of phosphopeptides database derived from phosphoproteomic studies we previously identified a list of potential new CK2 substrates, including, among others, Programmed Cell Death 5 (PDCD5), a protein involved in cell death and down-regulated in different forms of human tumors. Here we provide experimental evidence that PDCD5 is indeed a bona fide substrate of CK2. PDCD5 is phosphorylated in vitro by both CK2alpha subunit and by the CK2 holoenzyme at a residue, S118, which is found phosphorylated in vivo. We also show that PDCD5 is phosphorylated by CK2 in 293T cells. Transfection of the non-phosphorylatable mutant (S118A) impairs the PDCD5 acceleration of either doxorubimicin- or UV-induced apoptosis in U2OS cells. Our results suggest a functional link between the CK2 phosphorylation and the apoptotic potential of PDCD5.
Insights
Protein kinase CK2 phosphorylates Programmed Cell Death 5 (PDCD5), enhancing its role in apoptosis. This CK2-PDCD5 interaction is crucial for programmed cell death, particularly under stress conditions like doxorubicin or UV exposure.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Protein kinase CK2 (CK2) is a key regulator of numerous cellular processes, including cell growth and apoptosis.
- Programmed Cell Death 5 (PDCD5) is implicated in cell death pathways and is frequently downregulated in human tumors.
- Previous phosphoproteomic analyses suggested PDCD5 as a potential substrate of CK2.
Purpose of the Study:
- To experimentally validate Programmed Cell Death 5 (PDCD5) as a direct substrate of protein kinase CK2 (CK2).
- To investigate the functional consequences of CK2-mediated PDCD5 phosphorylation on apoptosis.
- To elucidate the role of CK2 phosphorylation at serine 118 (S118) in PDCD5's apoptotic function.
Main Methods:
- In vitro kinase assays using purified CK2 subunits and holoenzyme.
- In vivo phosphorylation studies in 293T cells.
- Site-directed mutagenesis to create a non-phosphorylatable PDCD5 mutant (S118A).
- Apoptosis assays in U2OS cells treated with doxorubicin or UV radiation.
Main Results:
- PDCD5 is confirmed as a bona fide substrate of CK2, with phosphorylation occurring at S118 both in vitro and in vivo.
- CK2 phosphorylates PDCD5 in human 293T cells.
- Expression of the non-phosphorylatable PDCD5 mutant (S118A) significantly reduced the acceleration of doxorubicin- or UV-induced apoptosis.
Conclusions:
- CK2 directly phosphorylates PDCD5 at S118, establishing a functional link between CK2 activity and PDCD5's pro-apoptotic function.
- CK2-mediated phosphorylation of PDCD5 is essential for its full contribution to apoptosis induction.
- These findings highlight a novel regulatory mechanism controlling apoptosis via the CK2-PDCD5 axis.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
15:43Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Related Concept Videos
Inhibition of Cdk Activity
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Positive Regulator Molecules
Positive Regulator Molecules